Covidien
edit

Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. Segments The company operates its businesses through four segments:

Medical Devices includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, vascular devices, SharpSafety products, clinical care products and other medical device products;

Imaging Solutions includes the development, manufacture and marketing of radiopharmaceuticals and contrast products;

Pharmaceutical Products includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients; and Medical Supplies includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products (OEM).

The Medical Device segment develops, manufactures and sells an array of products which the company categorizes in the following product groups:

Endomechanical Instrumentsâ€”includes its laparoscopic instruments and surgical staplers.
Soft Tissue Repair Productsâ€”includes its sutures, mesh and biosurgery products.
Energy Devicesâ€”includes its vessel sealing, electrosurgical and ablation products and related capital equipment. Oximetry and Monitoring Productsâ€”includes its sensors, monitors and temperature management products. Airway and Ventilation Productsâ€”includes its airway, ventilator, breathing systems, sleep and inhalation therapy products. Vascular Devicesâ€”includes its compression and vascular therapy products. SharpSafety Productsâ€”includes its needles, syringes and sharps disposable products. Clinical Care Productsâ€”includes its urology, enteral feeding and other advanced woundcare products.

Recent Milestones
edit

Covidien acquired Maya Medical. (5/9/12)

Posted 5/9/12 at 7:43pm via masshightech.com
Covidien acquired Oridion. (4/6/12)

Posted 4/6/12 at 7:21pm via masshightech.com
Covidien acquired SuperDimension. (3/19/12)

Posted 3/19/12 at 7:38pm via istockanalyst.com
Covidien acquired BARRX Medical for $325M. (11/21/11)

Posted 11/21/11 at 7:30pm via prnewswire.com
Covidien — Covidien inks new $1.5B credit deal (8/17/11)

Posted 8/17/11 at 8:31pm via masshightech.com
Covidien — Covidien CEO Meelia to retire (3/16/11)

Posted 3/16/11 at 8:00pm via masshightech.com
Covidien — announced that Richard J. Meelia will retire as President and CEO of the company, effective July 1 (3/16/11)

Posted 3/17/11 at 5:01am via masshightech.com
Covidien — has been cleared by the U.S. Food and Drug Administration to market in the U.S. its devices for lowering risk of deep vein thrombosis. (11/8/10)

Posted 11/9/10 at 5:10am via masshightech.com
Covidien acquired Aspect Medical Systems for $58M. (12/14/09)

Posted 12/17/09 at 3:54pm via masshightech.com
Covidien added Israel Kehat as Software Development Manager and Architect . (6/1/09)

Posted 5/15/13 at 4:00am
Covidien acquired CardioDigital. (8/7/08)

Posted 9/16/09 at 5:41pm
Covidien added Richard J. Meelia as CEO.

Posted 9/16/09 at 5:41pm
Covidien added Charles J. Dockendorff as CFO.

Posted 9/16/09 at 5:41pm
Covidien added Dennis H. Reilley as Former Chairman,.

Posted 4/25/13 at 7:34pm
Covidien added Rodney E.Marcy as Vice President of Global Market Development & Vice President of Sales.

Posted 5/1/13 at 12:53pm
Went public with stock symbol NYSE:COV.

Posted 11/9/09 at 3:44pm